Hennion & Walsh Asset Management’s Seres Therapeutics MCRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,055
| Closed | -$346K | – | 824 |
|
|
2023
Q1 | $346K | Sell |
3,055
-104
| -3% | -$11.8K | 0.02% | 600 |
|
|
2022
Q4 | $354K | Buy |
3,159
+399
| +14% | +$44.7K | 0.02% | 582 |
|
|
2022
Q3 | $354K | Sell |
2,760
-38
| -1% | -$4.87K | 0.02% | 560 |
|
|
2022
Q2 | $192K | Sell |
2,798
-42
| -1% | -$2.88K | 0.01% | 726 |
|
|
2022
Q1 | $404K | Buy |
2,840
+58
| +2% | +$8.25K | 0.02% | 563 |
|
|
2021
Q4 | $463K | Buy |
2,782
+174
| +7% | +$29K | 0.02% | 550 |
|
|
2021
Q3 | $363K | Buy |
2,608
+893
| +52% | +$124K | 0.02% | 589 |
|
|
2021
Q2 | $818K | Buy |
+1,715
| New | +$818K | 0.04% | 406 |
|